Abstract
A large number of therapeutic medications have undesirable properties that may generate pharmacological, pharmaceutical, or pharmacokinetic barriers in clinical drug applications. Metabolism of drugs by Phase-I & Phase-II metabolic pathways for possibility of active metabolites, which could in turn useful for rational designing of bioprecursor prodrugs of the active principle of interest. This review summarizes various approaches & development of drugs, namely bioprecursor prodrugs and active metabolites related to bioprecursor prodrugs.
Keywords: Bioprecursor prodrugs, active metabolites, oxidative activation, glucuronic acid conjugation, bioreductive alkylation, prodrugs, proagent, O-demethylated metabolite of phenacetin, phenacetin, OXIDATION, Cytochrome P450 Mono-Oxygenase, NADPH-CYP reductase, CYP enzymes, xenobiotics, Flavin-Containing Monooxygenase System, FMO family, lipophilic compounds, Monoamine Oxidase, neurotransmitter amines, clorgyline, serotonin, L-deprenyl, oxidize dopamine, tyramine, octopamine, hydrogen peroxide, NADPH-cytochrome P450 reductase, NADH-putidaredoxin reductase, Nabumetone, Dexpathenol, 3-pyridine methanol, mitomycin, nitrogen mustard, omeprazole, Sulindac, SAH 51-641, acyl CoA ligase, gluconeogenesis, aroylpropionic acids, aryl acetic acid, aroylpropionic acid, bucloxic acid, indomethacin, Idoxuridine, thymidine kinase, Methyltransferase, Glutathione S-Transferases, Sulfotransferases System, N-Acetyltransferases System, UDP-Glucuronosyltransferases, UDP, Minoxidil, paclitaxel
Mini-Reviews in Medicinal Chemistry
Title: Bioprecursor Prodrugs: Molecular Modification of the Active Principle
Volume: 10 Issue: 14
Author(s): Ganesh R. Kokil and Prarthana V. Rewatkar
Affiliation:
Keywords: Bioprecursor prodrugs, active metabolites, oxidative activation, glucuronic acid conjugation, bioreductive alkylation, prodrugs, proagent, O-demethylated metabolite of phenacetin, phenacetin, OXIDATION, Cytochrome P450 Mono-Oxygenase, NADPH-CYP reductase, CYP enzymes, xenobiotics, Flavin-Containing Monooxygenase System, FMO family, lipophilic compounds, Monoamine Oxidase, neurotransmitter amines, clorgyline, serotonin, L-deprenyl, oxidize dopamine, tyramine, octopamine, hydrogen peroxide, NADPH-cytochrome P450 reductase, NADH-putidaredoxin reductase, Nabumetone, Dexpathenol, 3-pyridine methanol, mitomycin, nitrogen mustard, omeprazole, Sulindac, SAH 51-641, acyl CoA ligase, gluconeogenesis, aroylpropionic acids, aryl acetic acid, aroylpropionic acid, bucloxic acid, indomethacin, Idoxuridine, thymidine kinase, Methyltransferase, Glutathione S-Transferases, Sulfotransferases System, N-Acetyltransferases System, UDP-Glucuronosyltransferases, UDP, Minoxidil, paclitaxel
Abstract: A large number of therapeutic medications have undesirable properties that may generate pharmacological, pharmaceutical, or pharmacokinetic barriers in clinical drug applications. Metabolism of drugs by Phase-I & Phase-II metabolic pathways for possibility of active metabolites, which could in turn useful for rational designing of bioprecursor prodrugs of the active principle of interest. This review summarizes various approaches & development of drugs, namely bioprecursor prodrugs and active metabolites related to bioprecursor prodrugs.
Export Options
About this article
Cite this article as:
R. Kokil Ganesh and V. Rewatkar Prarthana, Bioprecursor Prodrugs: Molecular Modification of the Active Principle, Mini-Reviews in Medicinal Chemistry 2010; 10 (14) . https://dx.doi.org/10.2174/138955710793564179
DOI https://dx.doi.org/10.2174/138955710793564179 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug-Induced Peripheral Neuropathy: Diagnosis and Management
Current Cancer Drug Targets From Body Art to Anticancer Activities: Perspectives on Medicinal Properties of Henna
Current Drug Targets Glycation and Hypoxia: Two Key Factors for Adipose Tissue Dysfunction
Current Medicinal Chemistry Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Current Medicinal Chemistry Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Current Pharmaceutical Design Role of Membrane Transporters and Metabolizing Enzymes in Ocular Drug Delivery
Current Drug Metabolism Signal Transduction and Photodynamic Therapy
Current Signal Transduction Therapy Metabolism of Rhaponticin and Activities of its Metabolite, Rhapontigenin: A Review
Current Medicinal Chemistry The Role of Exploratory Drug Metabolism and Pharmacokinetics in New Drug Research: Case Study-Selection of a Thrombin Receptor Antagonist for Development
Current Pharmaceutical Design Chemistry, Physiology, and Pharmacology of β-Adrenergic Mechanisms in the Heart. Why are β-Blocker Antiarrhythmics Superior?
Current Pharmaceutical Design ENaC Modulators and Renal Disease
Current Molecular Pharmacology Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry Lipid Raft Alterations in Aged-Associated Neuropathologies
Current Alzheimer Research Development and In Vitro Proof-of-Concept of Interstitially Targeted Zinc- Phthalocyanine Liposomes for Photodynamic Therapy
Current Medicinal Chemistry Heterocyclic Analogues as Kinase Inhibitors: A Focus Review
Current Topics in Medicinal Chemistry Integrative Control of Gastrointestinal Motility by Nitric Oxide
Current Medicinal Chemistry Nicotinamide Adenine Dinucleotide Based Therapeutics
Current Medicinal Chemistry Novel Molecular Targets in the Treatment of Cardiac Hypertrophy
Recent Patents on Cardiovascular Drug Discovery Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism Antibody-directed Double Suicide Gene Therapy Targeting of MUC1- Positive Leukemia Cells In Vitro and In Vivo
Current Gene Therapy